Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Dermatology
    • Tacrolimus combination...

    Tacrolimus combination superior to monotherapy for vitiligo treatment

    Written by Medha Baranwal Baranwal Published On 2019-07-29T19:20:44+05:30  |  Updated On 29 July 2019 7:20 PM IST
    Tacrolimus combination superior to monotherapy for vitiligo treatment

    Australia: Tacrolimus in combination with steroids, phototherapy and laser is superior to tacrolimus alone for vitiligo treatment, according to a recent study published in the Australasian Journal of Dermatology.


    Vitiligo is a disease that causes the loss of skin colour in blotches. It affects about 0.5% to 1% of the population and is associated with low self-esteem and social stigma. The medical approach to vitiligo patients is a complex process. Topical medications (corticosteroids and calcineurin inhibitors) and phototherapy are the mainstays of treatment.


    There are also other treatment options such as skin surgery and laser, but none of them has been able to provide consistent and satisfactory results in all patients.


    Topical calcineurin inhibitors (TCIs) including tacrolimus and pimecrolimus possess a dual mechanism of action for the treatment of vitiligo: immunosuppression and melanocyte induction. TCIs are recommended as first-line treatments for limited forms of vitiligo, however, the efficacy of TCI monotherapy is often underestimated.


    Charan Jeet Arora, Miranda Medical Centre, Miranda, New South Wales, Australia, and colleagues investigated the efficacy and safety of topical tacrolimus either as monotherapy or combined therapy in the treatment of vitiligo.


    The researchers carried out the electronic systematic search of the literature using four major databases. Randomised clinical trials (RCTs) that reported the use of topical tacrolimus in the treatment of human vitiligo were included in a systematic review and meta‐analysis. A total of 19 studies including 814 patients were included in our systematic review.


    Also Read: Topical calcineurin inhibitors show favorable therapeutic response in Vitiligo


    Key Findings of the study include:




    • In the random-effects-model meta-analysis tacrolimus plus narrowband ultraviolet B (NB-UVB) was better in achieving >75% repigmentation than NB-UVB alone.

    • Tacrolimus vs steroids did not differ in achieving: >25%, >50%, and >75% repigmentation.

    • No significant difference was observed between fractional laser plus tacrolimus in achieving >25% and >75% repigmentation.

    • Excimer laser plus tacrolimus vs excimer laser alone did not differ in achieving >25%, >50%, and >75% repigmentation.


    Also Read: Topical cream ruxolitinib shows promise in vitiligo, finds clinical trial


    "Further investigating tacrolimus as mono‐ or adjuvant therapy for vitiligo is highly recommended," concluded the authors.


    To read the complete study log on to https://doi.org/10.1111/ajd.13096

    blotchescalcineurin inhibitorsCharan Jeet AroraLaserMedical newsphototherapypigmentationrecent medical newsrepigmentationskin colorsteroidstacrolimustopical calcineurin inhibitorstopical medicationstreatmentultraviolet Bvitiligo

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok